We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Treatment of Late Abortion: Evacuatio Uteri or Conservative Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00256009
Recruitment Status : Unknown
Verified November 2005 by Rigshospitalet, Denmark.
Recruitment status was:  Not yet recruiting
First Posted : November 21, 2005
Last Update Posted : June 1, 2006
Information provided by:
Rigshospitalet, Denmark

Brief Summary:
A randomize trial: expectation or evacuatio uteri for the treatment after late abortion

Condition or disease Intervention/treatment Phase
Abortion, Spontaneous Abortion, Induced Drug: Cytotec Phase 4

Detailed Description:
A randomize trial adressing 200 women consecutively recruited from clinical practice at Rigshospitalet.Expectation: administration of 800 microgram Cytotec half an hour after delivery. Surgery: Evacuation of the uterus

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evacuatio Uteri or Conservtive Treatment After Late Abortion. A Randomize Trial.
Study Completion Date : January 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Abortion
Drug Information available for: Misoprostol

Primary Outcome Measures :
  1. Side-effect
  2. Complication

Secondary Outcome Measures :
  1. Quality of life

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

abortion at gestational age (ultrasound) 14+0 - 20+0

Exclusion Criteria:

Allergy to cytotec

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00256009

Layout table for location contacts
Contact: Lars Alling Møller, Md phd 0045 35451338 Lars.Alling@rh.dk

Sponsors and Collaborators
Rigshospitalet, Denmark
Layout table for investigator information
Principal Investigator: Lars Alling Møller, MD phd Rigshospitalet, Denmark
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00256009    
Other Study ID Numbers: KF 01 279545
First Posted: November 21, 2005    Key Record Dates
Last Update Posted: June 1, 2006
Last Verified: November 2005
Keywords provided by Rigshospitalet, Denmark:
Late abortion
Additional relevant MeSH terms:
Layout table for MeSH terms
Abortion, Spontaneous
Pregnancy Complications
Abortifacient Agents, Nonsteroidal
Abortifacient Agents
Reproductive Control Agents
Physiological Effects of Drugs
Anti-Ulcer Agents
Gastrointestinal Agents